News & Insights
Company announcements, research publications, conference presentations, and industry partnerships.
A joint poster at the 39th ECNP Congress in Munich examines how EEG spectral features behave in generalized anxiety disorder across a large, real-world hospital population.
Brainify.AI has placed 4th among the winners of HealthTech44 2026, TechRound's annual awards recognizing the most promising companies in health technology.
Brainify.AI's new longevity platform brings measurable cognitive wellness to The Longevity Suite's Riyadh clinic, marking its debut in the luxury longevity market.
At TEDxBerlin Salon, Brainify.AI co-founder Mariam Khayretdinova calls for a massive communal effort to create a "global biobank" — pooling diverse biological data to finally make mental disorders measurable and empower AI to develop precise treatments.
Ivan Mishanin, Co-founder and COO, will be attending the 44th Annual J.P. Morgan Healthcare Conference from January 12-15, 2026.
Brainify.AI Co-founder & CEO Mariam Khayretdinova will join industry leaders as a panelist at the Beryl Elites & Silverstein Dream Foundation event at World Trade Center, NYC.
Brainify.AI and Negev Labs leveraged AI to rapidly identify new CNS therapeutic opportunities, reducing research time from a year to under four weeks and saving up to $400,000.
Brainify.AI partners with Reguard Health to distribute BREEG™ EEG technology across Europe, enhancing brain health diagnostics in key markets like Italy, Germany, Switzerland, and Poland.
Brainify.AI earns Honorable Mention in the Biotech category at the Nebius AI Discovery Awards 2025 for its groundbreaking work in transforming EEG data into clinical biomarkers.
Brainify.AI's new research uses EEG and deep learning to predict placebo response, revolutionizing CNS trials and advancing personalized psychiatry.
Brainify.AI CEO Mariam Khayretdinova discusses AI's role in transforming mental health care at the 2025 Integrated Cure Conference.
Explore groundbreaking research on EEG biomarkers in precision psychiatry published on Nature.com. Learn how AI-driven models enhance treatment outcomes and personalize psychiatric care.
Join Mariam Khayretdinova at MIT Media Lab for insights on AI's role in enhancing psychiatric care.
Jim Doherty, seasoned CNS R&D leader, joins Brainify.AI's advisory board, bringing over two decades of pharmaceutical expertise and innovative leadership.
CEO Mariam Khayretdinova represents Brainify.AI at an HBS healthcare innovation event.
CEO Mariam Khayretdinova showcases the transformative role of AI in psychiatry at the World Economic Forum, emphasizing the impact on drug discovery and personalized treatment strategies for depression.
Brainify.AI CEO Mariam Khayretdinova to Present Breakthroughs in Precision Psychiatry at Biotech Showcase 2024.
Brainify.AI, a leader in precision psychiatry, joins the Merck Digital Sciences Studio program. Their AI-driven products aim to enhance clinical trials and develop companion diagnostics for mental health disorders.
Brainify.AI collaborates with Clerkenwell Health to revolutionize psychiatric clinical trials with AI biomarker technology for improved patient outcomes.
Brainify.AI has been accepted into the prestigious Harvard Innovation Lab ecosystem that works with hundreds of student startups each year.
Brainify.AI and HIVE BIO Forge Game-Changing Partnership to Catalyze the Future of Precision Psychiatry With Proprietary EEG Biomarkers.
Brainify AI, led by CEO Mariam Khayretdinova, joins industry experts to discuss revolutionary applications of AI in healthcare at Plug and Play's prestigious event.
Brainify.AI CEO Mariam Khayretdinova joins 25+ experts at the 6th Annual Neuropsychiatric Drug Development Summit to reveal groundbreaking advances in depression treatment prediction.
Brainify.AI is excited to announce it has joined Johnson & Johnson Innovation–JLABS (JLABS) as a resident company.
Brainify.AI's CEO, Mariam Khayretdinova, will present her pioneering work in AI and mental health at the New York Young Startup Summit.
Harvard's Extension School graduate Mariam Khayretdinova takes a bold step in treating depression through Brainify.AI.
Deep Pharma Intelligence recognizes Brainify.AI's contributions to AI in the Drug Discovery industry.
Brainify.AI, leading the AI revolution in depression treatment, is highlighted in US Venture News' Startup Showcase.
Mariam Khayretdinova, CEO of Brainify.AI, discusses the application of AI in combating depression in an exclusive interview with Nasdaq.
Mariam Khayretdinova, CEO of Brainify.AI, showcases the company's technology at MIT's prestigious CSAIL event.
Ivan Mishanin, COO of Brainify.AI, shares 7 tips for successful business growth in Entrepreneur.
TEDxBoston hosts talk by Mariam Khayretdinova on AI transforming personalized psychiatry.
Ivan Mishanin, COO of Brainify.AI, discusses entrepreneurship challenges and strategies for global growth.
Mariam Khayretdinova discusses AI's role in addressing female depression on the InfluenceHER podcast.
Our CEO Mariam Khayretdinova pitched Brainify.AI to over 2700 attendees at the prestigious Harvard competition.
Brainify.AI presents findings on data leakage in large-scale EEG datasets at ISBI 2023, highlighting the need for data harmonization tools.
Learn from Brainify.AI co-founder Ivan Mishanin as he shares insights on overcoming deep tech startup challenges and revolutionizing industries like biotechnology.
Discover the challenges and opportunities in depression treatment development. Explore rising costs, low approval rates, and emerging solutions.
HackerNoon interviews Brainify.AI's co-founder and COO, Ivan Mishanin, on his journey as a tech entrepreneur and the future of mental health treatment.
Discover how Brainify.AI streamlines clinical trials and improves patient outcomes by leveraging AI/ML technology and a diverse patient dataset.
Explore Michelle Tennant Nicholson's interview with Brainify.AI CEO Mariam Khayretdinova on championing mental wellness.
Brainify.AI has been named a life science finalist in the President's Innovation Challenge at Harvard Innovation Lab, where over 340 startups applied across 5 categories.
Disruptive Technologists interview Brainify.AI's CEO Mariam Khayretdinova on her quest to help female depression through technology.
Join Brainify.AI at VIVE2023 and be a part of this incredible event for networking, learning, and growth in the industry.
Brainify.AI's COO, Ivan Mishanin, will attend the Hello Tomorrow Global Summit in Paris this week as a Deep Tech Pioneer.
Brainify.AI attends the Wall Street Journal Health Forum 2023.
Don't miss Brainify.AI's showcase of its AI-powered healthcare solutions at Biotech Showcase 2023 in San Francisco.
Brainify.AI has published a manuscript on the prediction of brain age using DCNN, with multiple potential applications.
Brainify.AI has been named a Deep Tech Pioneer by Hello Tomorrow, recognizing the potential of its solutions.
Brainify.AI attends HLTH 2022, the premier healthcare conference.
We are thrilled to announce that Brainify.AI has been accepted into the prestigious Harvard Innovation Lab.
Our research featured at leading scientific conferences worldwide.
Orlando, FL • July 2024
"EEG Biomarkers for Precision Psychiatry"
Boston, MA • October 2024
"Real-World Brain Data at Scale"
Cartagena, Colombia • April 2023
"Foundational Models for EEG Analysis"
Virtual • March 2023
"Age-Related EEG Changes in Large Cohorts"
Partnering with the world's leading healthcare and technology organizations.
Life Sciences Venture Incubation Program
Healthcare Innovation Accelerator
Digital Health Partnership Program
Azure for Health & Life Sciences
AI Startup Acceleration Program